Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients.

MLA

Matikainen, T., et al. “Effects of Oestrogen Treatment on Serum Gonadotrophin Bioactivity, Immunoreactivity and Isohormone Distribution, and on Immunoreactive Inhibin Levels, in Prostatic Cancer Patients.” Clinical Endocrinology, vol. 40, no. 6, June 1994, pp. 743–50. EBSCOhost, https://doi.org/10.1111/j.1365-2265.1994.tb02507.x.

APA

Matikainen, T., Haavisto, A. M., Permi, J., de Kretser, D., & Huhtaniemi, I. (1994). Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients. Clinical Endocrinology, 40(6), 743–750. https://doi.org/10.1111/j.1365-2265.1994.tb02507.x

Chicago

Matikainen, T, A M Haavisto, J Permi, D de Kretser, and I Huhtaniemi. 1994. “Effects of Oestrogen Treatment on Serum Gonadotrophin Bioactivity, Immunoreactivity and Isohormone Distribution, and on Immunoreactive Inhibin Levels, in Prostatic Cancer Patients.” Clinical Endocrinology 40 (6): 743–50. doi:10.1111/j.1365-2265.1994.tb02507.x.